← SynDRA
RELCOVAPTAN
SynDRA canonical compound SYN0003541 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AVPR1A |
| Mechanism of action | Vasopressin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Vasopressin receptor antagonist
- AVPR1A ANTAGONIST
- Vasopressin V1a receptor antagonist
- OXTR ANTAGONIST
- Oxytocin receptor antagonist
- AVPR1A INHIBITOR
Drug classes
- Hormone Antagonists
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- SR 49059
- SR49059
- TDI-0134
- SR-49059
- Relcovaptan [INN]
- UNII-C1GL8G6G0O
- C1GL8G6G0O
- CHEMBL419667
- 1-(5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl)pyrrolidine-2-carboxamide
- (2S)-1-[[(2R,3S)-5-CHLORO-3-(2-CHLOROPHENYL)-1-[(3,4-DIMETHOXYPHENYL)SULFONYL]-2,3-DIHYDRO-3-HYDROXY-1H-INDOL-2-YL]CARBONYL]-2-PYRROLIDINECARBOXAMIDE
- 2-Pyrrolidinecarboxamide,
- [3H]relcovaptan
- TDI 0134
- DTXCID9025746
- relcovaptanum
- RefChem:879222
- MFCD00922133
- C28H27Cl2N3O7S
- NCGC00092366-02
- [3H]SR49059
- [3H]SR-49059
- Relcovaptan [WHO-DD]
- [3H] SR 49059
- GTPL2200
- GTPL3482
- orb1704036
- SCHEMBL4387208
- SCHEMBL29381874
- SCHEMBL30027840
- CHEBI:93701
- GLXC-06159
- HMS3268L06
- HMS3413E08
- HMS3677E08
- AGA37575
- BDBM50114031
- EX-A14390
- AKOS024457044
Look up RELCOVAPTAN in the interactive SynDRA portal →